| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Annovis Bio, Inc. (ANVS) has 5 insiders with recent SEC Form 4 filings, including 8 buys and 0 sells. ANVS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.57M | $5.77M | - | |
| CEO | 1.21M | $2.71M | - | |
| Dir | 9.3K | $20.8K | - | |
| VP | 500 | $1.1K | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2020 | McGroarty Jeffrey Brian | Chief Financial Officer | Buy | 52,833 | $6.42 | $339,426.28 | +61.4% | |
| Jan 31, 2020 | White Mark K. | Director | Buy | 1,734 | $6.00 | $10,404.00 | New | |
| Jan 31, 2020 | Hoffman Michael B | Director, 10% Owner | Buy | 33,333 | $6.00 | $199,998.00 | +233.3% | |
| Jan 31, 2020 | MacCecchini Maria-Luisa | President And CEO | Buy | 1,600 | $6.00 | $9,600.00 | +0.8% | |
| Jan 31, 2020 | Bruck Claudine | Director | Buy | 800 | $6.00 | $4,800.00 | New | |
| Jan 31, 2020 | Whelan, Jr. Robert M. | Director | Buy | 25,000 | $6.00 | $150,000.00 | New |